EurekAlert! -
16 Apr 2020 06:00
(University of Pennsylvania School of Medicine) A new trial will evaluate whether the use of medications to treat high blood pressure affect outcomes among patients who are prescribed the medication and hospitalized with COVID-19. As part of the multi-center, international trial called REPLACE COVID, investigators will examine whether ACE inhibitors (ACEI) or Angiotensin Receptor Blockers (ARBs) -- two classes of medications to treat high blood pressure -- help to mitigate complications or lead ...
Share this Article